Chenggong Yu

Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy.

Jingde Wu, Ying Qu, Jun Wang, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Structure optimization and preliminary bioactivity evaluation of N-hydroxybenzamide-based HDAC inhibitors with Y-shaped cap.

Jingde Wu, Ying Qu, Ana Xu, 2018, Bioorganic & medicinal chemistry.

A Toolbox for Constructing a Stable Genetic Transformation Platform Allowing Foreign Fragment Integration in the Genome of Neopyropia yezoensis

Xianghai Tang, Y. Mao, Fanna Kong, 2022, Frontiers in Marine Science.

The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease

Jingde Wu, Ying Qu, Yingying Ran, 2019, ChemistrySelect.

Advances on graphene-based nanomaterials for biomedical applications.

Qiuqiong Zhang, Jingde Wu, Jingde Wu, 2018, Materials science & engineering. C, Materials for biological applications.

Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer's disease.

Jingde Wu, C. Chou, Xiaoyang Li, 2020, Bioorganic chemistry.

Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors.

Jingde Wu, Ying Qu, Ana Xu, 2019, Bioorganic & medicinal chemistry.